GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: OVSC
Outperform $12

Ovascience (NASDAQ: OVAS) reiterated to Outperform with price target $12 by Oppenheimer

Wednesday,  Sep 30, 2015  10:25 AM ET by Betsy O'Brien Harrison

Oppenheimer reiterated Ovascience (NASDAQ: OVAS) to Outperform with price
target $12. Previously Oppenheimer reiterated Ovascience (NASDAQ: OVAS) to Outperform on 12/24/2014, when the stock price was $42.89.



OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy